Schedule 13G ownership disclosure

CITIUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 17322U207

Event date: 2018-03-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
648,728
Percent of class
6.0800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-18-000075
Form type
SC 13G
Filer
Citius Pharmaceuticals, Inc.
CIK
CIK 1506251
Filed
Mar 29, 2018
Reporting period
Mar 28, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub